Products and methods for treating muscular dystrophy

A nucleic acid comprising a nucleotide sequence selected from the group consisting of:

• (a) a nucleotide sequence comprising at least 80% identity to the sequence set forth in any one of SEQ ID NOs:
• 1-20;
• (b) a nucleotide sequence complementary to the nucleotide sequence comprising at least 80% identity to the sequence set forth in any one of SEQ ID NOs:
• 1-20;
• (c) a nucleotide sequence comprising the sequence set forth in any one of SEQ ID NOs:
• 1-20;
• (d) a nucleotide sequence complementary to the nucleotide sequence comprising the sequence set forth in any one of SEQ ID NOs:
• 1-20;
• and
• (e) a nucleotide sequence which binds to the sequence set forth in any one of SEQ ID NOs:
• 21-25.